0001127602-17-014039.txt : 20170404 0001127602-17-014039.hdr.sgml : 20170404 20170404172857 ACCESSION NUMBER: 0001127602-17-014039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170403 FILED AS OF DATE: 20170404 DATE AS OF CHANGE: 20170404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIBERSTEIN KATHRYN L CENTRAL INDEX KEY: 0001235595 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 17739790 MAIL ADDRESS: STREET 1: 88 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 021394136 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-04-03 0001520262 Alkermes plc. ALKS 0001235595 BIBERSTEIN KATHRYN L 852 WINTER ST. WALTHAM MA 02451 1 EVP/CAO/CCO Alks Inc; Sec ALKS Ordinary Shares 2017-04-03 4 M 0 15000 15.95 A 69904 D Ordinary Shares 2017-04-03 4 S 0 10937 57.4114 D 58967 D Ordinary Shares 2017-04-03 4 S 0 3763 58.3544 D 55204 D Ordinary Shares 2017-04-03 4 S 0 300 59.125 D 54904 D Ordinary Shares 36848 I By 2015 GRAT Ordinary Shares 57152 I By 2016 GRAT Non Qualified Stock Option (Right to Buy) 15.95 2017-04-03 4 M 0 15000 0 D 2017-06-01 Ordinary Shares 15000 0 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.04 to $58.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.05 to $59.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.05 to $59.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Shares held by the 2015 GRAT. The Reporting Person is a trustee and beneficiary of the 2015 GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the 2015 GRAT. Shares held by the 2016 GRAT. The Reporting Person is a trustee and beneficiary of the 2016 GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the 2016 GRAT. These options are fully vested in accordance with their terms. /s/ Jennifer Baptiste, attorney-in-fact for Kathryn L. Biberstein 2017-04-04